Researchers examined the safety and efficacy of daily vs weekly levothyroxine therapy for hypothyroidism in young and middle aged adults.
Miscarriage risk before 20 weeks of gestation is higher among women with untreated subclinical hypothyroidism.
Researchers noted a significant increase in serum vitamin D and significant reductions in TSH following 3 months of vitamin D supplementation.
Physicians need to be aware of silent thyroiditis as a rare but serious side effect of lithium therapy.
Cognitive function was affected even in patients with subclinical hypothyroidism.
Elemental calcium — found in cow's milk — significantly limits a person's ability to absorb oral levothyroxine.
Tirosint-SOL (levothyroxine sodium oral solution) should be available within the next 6 months.
Women with subclinical hypothyroidism who undergo thyroid hormone treatment have a decreased risk of pregnancy loss, but may experience other pregnancy-related adverse outcomes.
Early detection and quick treatment with levothyroxine are essential in treating children with congenital hypothyroidism.
Half of the infants in the study had a delayed diagnosis of congenital hypothyroidism.
Endocrinology Advisor Articles
- Maternal Deaths in the United States: Sounding a Call to Action
- Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes
- Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control
- Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine
- The Handoff: Your Week in Endocrinology News - 6/23/17
- Reduced Cardiovascular Events in Type 2 Diabetes Treated With Dapagliflozin
- Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes
- Diabetic Retinopathy Caused by Sleep Apnea in T2D
- Transition-of-Care Algorithm Performs Well in Surgery Patients With Type 2 Diabetes
- GLP-1 Analog Counteracts Antipsychotic-Induced Glucose Intolerance, Weight Gain